Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 226.4 SEK -1.14% Market Closed
Market Cap: 30.7B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Capital Expenditures Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
SOBI
BIOA B

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Capital Expenditures
-kr156m
CAGR 3-Years
-73%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Capital Expenditures
-kr48.6m
CAGR 3-Years
-45%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Capital Expenditures
-kr8.4m
CAGR 3-Years
-66%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Capital Expenditures
-kr11.9m
CAGR 3-Years
0%
CAGR 5-Years
-31%
CAGR 10-Years
-47%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Capital Expenditures
-kr3.4B
CAGR 3-Years
-9%
CAGR 5-Years
18%
CAGR 10-Years
-42%
BioArctic AB
STO:BIOA B
Capital Expenditures
-kr7.4m
CAGR 3-Years
16%
CAGR 5-Years
-12%
CAGR 10-Years
N/A

See Also

What is Vitrolife AB's Capital Expenditures?
Capital Expenditures
-156m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Capital Expenditures amounts to -156m SEK.

What is Vitrolife AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-15%

Over the last year, the Capital Expenditures growth was -53%. The average annual Capital Expenditures growth rates for Vitrolife AB have been -73% over the past three years , -15% over the past five years .

Back to Top